Status | Study |
RECRUITING |
Study Name: A Study of Deucravacitinib to Treat LPP and FFA Condition: Lichen Planopilaris Date: 2023-10-16 Interventions: 6 milligram (mg) orally administrated, twice daily |
Recruiting |
Study Name: Design and Validation of a New Assessment Tool for Lichen Planopilaris Condition: Lichen Planopilaris of Scalp Lichen Plano Date: 2017-03-13 Interventions: Diagnostic Test: Boston Grade of Activity in Lichen Planopilaris A clinical assessment tool to objective |
Completed |
Study Name: Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia Condition: Central Centrifugal Scarring Alopecia Lichen Planopilaris Date: 2008-06-02 |